521 related articles for article (PubMed ID: 17307973)
1. In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii.
Scheetz MH; Qi C; Warren JR; Postelnick MJ; Zembower T; Obias A; Noskin GA
Antimicrob Agents Chemother; 2007 May; 51(5):1621-6. PubMed ID: 17307973
[TBL] [Abstract][Full Text] [Related]
2. In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii.
Song JY; Kee SY; Hwang IS; Seo YB; Jeong HW; Kim WJ; Cheong HJ
J Antimicrob Chemother; 2007 Aug; 60(2):317-22. PubMed ID: 17540672
[TBL] [Abstract][Full Text] [Related]
3. Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU.
Sheng WH; Wang JT; Li SY; Lin YC; Cheng A; Chen YC; Chang SC
Diagn Microbiol Infect Dis; 2011 Jul; 70(3):380-6. PubMed ID: 21558048
[TBL] [Abstract][Full Text] [Related]
4. Activity of tigecycline (GAR-936) against Acinetobacter baumannii strains, including those resistant to imipenem.
Pachón-Ibáñez ME; Jiménez-Mejías ME; Pichardo C; Llanos AC; Pachón J
Antimicrob Agents Chemother; 2004 Nov; 48(11):4479-81. PubMed ID: 15504889
[TBL] [Abstract][Full Text] [Related]
5. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan.
Liu JW; Wang LS; Cheng YJ; Hsu GJ; Lu PL; Liu YC; Chen CM; Lee CM; Sun W; Jang TN; Chiang PC; Chuang YC; Lin HC; Shi ZY; Kung HC; Huang CH; Tsao SM; Lu CT; Liao CH; Hsueh PR
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S188-91. PubMed ID: 19013353
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of various combinations of antimicrobials against carbapenem-resistant Acinetobacter species in Singapore.
Lim TP; Tan TY; Lee W; Sasikala S; Tan TT; Hsu LY; Kwa AL
J Antibiot (Tokyo); 2009 Dec; 62(12):675-9. PubMed ID: 19876075
[TBL] [Abstract][Full Text] [Related]
7. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.
Navon-Venezia S; Leavitt A; Carmeli Y
J Antimicrob Chemother; 2007 Apr; 59(4):772-4. PubMed ID: 17353223
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of tigecycline against clinical isolates of multidrug-resistant Acinetobacter baumannii in Siriraj Hospital, Thailand.
Tiengrim S; Tribuddharat C; Thamlikitkul V
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S102-5. PubMed ID: 17718251
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of tigecycline alone and in combination with colistin sulfate or sulbactam against carbapenem-susceptible and -resistant Acinetobacter baumannii strains isolated from Intensive Care Units.
Ozbek B; Otük G
Int J Antimicrob Agents; 2010 Aug; 36(2):191-2. PubMed ID: 20537868
[No Abstract] [Full Text] [Related]
10. In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Cha R
Pharmacotherapy; 2008 Mar; 28(3):295-300. PubMed ID: 18294108
[TBL] [Abstract][Full Text] [Related]
11. Determination of the pharmacodynamic activity of clinically achievable tigecycline serum concentrations against clinical isolates of Escherichia coli with extended-spectrum beta-lactamases, AmpC beta-lactamases and reduced susceptibility to carbapenems using an in vitro model.
Zhanel GG; Baudry PJ; Tailor F; Cox L; Hoban DJ; Karlowsky JA
J Antimicrob Chemother; 2009 Oct; 64(4):824-8. PubMed ID: 19643776
[TBL] [Abstract][Full Text] [Related]
12. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
13. Individual or Combined Effects of Meropenem, Imipenem, Sulbactam, Colistin, and Tigecycline on Biofilm-Embedded Acinetobacter baumannii and Biofilm Architecture.
Wang YC; Kuo SC; Yang YS; Lee YT; Chiu CH; Chuang MF; Lin JC; Chang FY; Chen TL
Antimicrob Agents Chemother; 2016 Aug; 60(8):4670-6. PubMed ID: 27216052
[TBL] [Abstract][Full Text] [Related]
14. Comparative time-kill study of doxycycline, tigecycline, sulbactam, and imipenem against several clones of Acinetobacter baumannii.
Bantar C; Schell C; Posse G; Limansky A; Ballerini V; Mobilia L
Diagn Microbiol Infect Dis; 2008 Jul; 61(3):309-14. PubMed ID: 18375084
[TBL] [Abstract][Full Text] [Related]
15. In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates.
Tan TY; Ng LS; Tan E; Huang G
J Antimicrob Chemother; 2007 Aug; 60(2):421-3. PubMed ID: 17540671
[TBL] [Abstract][Full Text] [Related]
16. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
Jamal W; Salama M; Dehrab N; Al Hashem G; Shahin M; Rotimi VO
J Hosp Infect; 2009 Jul; 72(3):234-42. PubMed ID: 19493588
[TBL] [Abstract][Full Text] [Related]
17. In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii.
Housman ST; Hagihara M; Nicolau DP; Kuti JL
J Antimicrob Chemother; 2013 Oct; 68(10):2296-304. PubMed ID: 23710070
[TBL] [Abstract][Full Text] [Related]
18. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan determined by the broth microdilution and disk diffusion methods.
Liao CH; Kung HC; Hsu GJ; Lu PL; Liu YC; Chen CM; Lee CM; Sun W; Jang TN; Chiang PC; Cheng YJ; Lin HC; Shi ZY; Wang LS; Chuang YC; Tsao SM; Lu CT; Liu JW; Huang CH; Hsueh PR
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S192-6. PubMed ID: 19013354
[TBL] [Abstract][Full Text] [Related]
19. Mutant prevention concentration of tigecycline for carbapenem-susceptible and -resistant Acinetobacter baumannii.
Cui JC; Liu YN; Chen LA
J Antibiot (Tokyo); 2010 Jan; 63(1):29-31. PubMed ID: 19911030
[No Abstract] [Full Text] [Related]
20. Activity of Omadacycline Alone and in Combination against Carbapenem-Nonsusceptible Acinetobacter baumannii with Varying Minocycline Susceptibility.
Abbey T; Vialichka A; Jurkovic M; Biagi M; Wenzler E
Microbiol Spectr; 2022 Jun; 10(3):e0054222. PubMed ID: 35647655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
